A narrative review of research advances in hypoxic pulmonary hypertension

Chai, Tianci; Qiu, Chen; Xian, Zhihong; Lu, Yongzhen; Zeng, Yuwei; Li, Jie

2022-02-01

10.21037/atm-22-259

Annals of Translational Medicine   影响因子和分区

2305-5839

2305-5847

["Background and Objective: Hypoxic pulmonary hypertension (HPH) is a pathological syndrome characterized by pulmonary vasoconstriction and pulmonary vascular remodeling caused by hypoxia, which eventually leads to right heart failure or death. There are 2 stages of onset of HPH: hypoxic pulmonary vasoconstriction (HPV) and hypoxic pulmonary vascular remodeling (HPVR). It is an important pathophysiological link in the pathogenesis of chronic obstructive pulmonary disease (COPD) and chronic mountain sickness (CMS), and its severity is closely related to the course and prognosis of COPD and CMS. However, there is a lack of systematic review on the diagnosis, pathogenesis and treatment of HPH. The objective of this paper is to review the diagnosis, pathogenesis, treatment of HPH.","Methods: In this paper, the method of literature review is adopted to obtain the information about HPH. Based on the literature, comprehensive and systematic review is made. The diagnosis, pathogenesis, treatment of HPH are summarized.","Key Content and Findings: Right heart catheterization is the gold standard for diagnosing HPH. Hypoxia-inducible factor, oxidative stress, metal metabolism, ion channel, inflammatory cytokines, cell apoptosis and vascular factors are the main pathogenesis of HPH. The treatment of HPH includes long-term oxygen therapy, statins, prostaglandins, phosphodiesterase inhibitor and ET receptor antagonists.","Conclusions: Although great progress has been made in the pathophysiology and molecular biology of HPH, it is still unclear which factors play a leading role in the pathogenesis of HPH, and no breakthrough has been made in the treatment of HPH. It is believed that the specific mechanism will be revealed as the research continues, and earlier diagnosis and the development of more effective targeted drugs will be the focus of future research."]

Hypoxic pulmonary hypertension (HPH) hypoxic pulmonary vasoconstriction (HPV) hypoxic pulmonary vascular remodeling (HPVR) hypoxia-inducible factor (HIF)

SCI

英语

第一 ; 通讯

Project of Shenzhen Basic Research Plan[JCYJ20210324114205014] ; Key Laboratory of Shenzhen Respiratory Disease[ZDSYS201504301616234]

Oncology ; Research & Experimental Medicine

Oncology ; Medicine, Research & Experimental

WOS:000766140700071

AME PUBL CO

Web of Science

Southern Univ Sci & Technol, Key Lab Shenzhen Resp Dis, Shenzhen Inst Resp Dis,Jinan Univ, Shenzhen Peoples Hosp,Affiliated Hosp 1,Clin Med, Shenzhen 518020, Peoples R China

Chai, Tianci,Qiu, Chen,Xian, Zhihong,et al. A narrative review of research advances in hypoxic pulmonary hypertension[J]. Annals of Translational Medicine,2022,10(4).

Chai, Tianci,Qiu, Chen,Xian, Zhihong,Lu, Yongzhen,Zeng, Yuwei,&Li, Jie.(2022).A narrative review of research advances in hypoxic pulmonary hypertension.Annals of Translational Medicine,10(4).

Chai, Tianci,et al."A narrative review of research advances in hypoxic pulmonary hypertension".Annals of Translational Medicine 10.4(2022).